Immunogenetic HLA-DQ and IgG serological profiles in individuals with self-reported wheat/gluten sensitivity: a retrospective real-world evidence study - Scorecard - MDSpire

Immunogenetic HLA-DQ and IgG serological profiles in individuals with self-reported wheat/gluten sensitivity: a retrospective real-world evidence study

  • By

  • Andreina White

  • Julie Verzura

  • Mariana White

  • Carol Rodríguez

  • Mercedes White

  • Milaidi García Bravo

  • May 25, 2026

  • 0 min

Share

Clinical Scorecard: Immunogenetic and Serological Profiles of HLA-DQ and IgG in Patients Reporting Wheat/Gluten Sensitivity: A Retrospective Analysis of Real-World Evidence

At a Glance

CategoryDetail
ConditionSelf-Reported Wheat/Gluten Sensitivity (SRWGS)
Key MechanismsHLA-DQ genotyping and serum IgG reactivity testing
Target PopulationSymptomatic individuals aged 10–80 years with gastrointestinal and systemic symptoms associated with wheat/gluten consumption
Care SettingSpecialized immunonutrition clinic (NutriWhite)

Key Highlights

  • 100% cumulative frequency of HLA-DQ susceptibility variants observed
  • DQ1 (56%) and DQ2 (54%) were the most prevalent alleles
  • Specific IgG reactivity occurred in 68% of cases, indicating strong correlation with wheat-gluten
  • Significant markers include DQ8 (p=0.001) and DQ3 (p=0.028)
  • IgG cross-reactivity supports the 'wheat/gluten complex' as an immunological unit

Guideline-Based Recommendations

Diagnosis

  • Characterization of biological profiles is essential for precision management

Management

  • Development of personalized nutritional strategies to address systemic manifestations associated with wheat exposure

Monitoring & Follow-up

  • Assessment of HLA-DQ allele frequency and IgG reactivity in symptomatic individuals

Risks

  • Increased intestinal permeability may lead to immune dysregulation and chronic inflammation

Patient & Prescribing Data

100 symptomatic individuals with self-reported wheat/gluten sensitivity

Emerging research suggests food-specific IgG may serve as a biomarker of increased intestinal permeability

Clinical Best Practices

  • Utilization of Real-World Evidence for understanding patient populations
  • Informed consent and ethical considerations in data collection

Related Resources & Content

Original Source(s)

Related Content